Stelis Biopharma’s CDMO partner receives approval for key ANDA from the USFDA
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
WHO made a strong recommendation for nirmatrelvir and ritonavir for mild and moderate COVID-19 patients at highest risk of hospital admission
The organisation is also working towards providing skills based training programmes to the workers for paramedical jobs and has launched certificate courses in ten disciplines
Miravo to remain a Canadian controlled and operated company following closing of the transaction
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Subscribe To Our Newsletter & Stay Updated